Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
rabbit, European |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Antigen (Ag) recognition by the T cell receptor (TCR) induces activation ofT lymphocytes. However, TCR-mediated signals alone are insufficient forefficient T cell activation, and additional co-stimulatory signals are required. One of the most important surface molecules that delivers co-stimulatory signals for T cells is CD28. The human T lymphocyte Ag CD28 (Tp44) is a homodimeric 90kDa glycoprotein expressed on the surface of themajority of human peripheral T cells and lymphocytes. Stimulation of CD4+ Tcells in the absence of CD28 co-signalling causes impaired proliferation, reduced cytokine production and altered generation of helper T cell subsets.Co-stimulation via CD28 promotes T cell viability, clonal expansion,cytokine production and effector functions, while also regulating apoptosisof activated T cells, suggesting its importance in regulating long-term T cell survival [, , , ].Ligands for CD28 and the structurally related CTLA-4 (CD152) are themolecules B7.1 (CD80) and B7.2 (CD86). B7.1 and B7.2 are expressed onprofessional antigen presenting cells (APCs) and their expression is up-regulated during an immune response. Ligation of CD28 by its natural ligandsresults in tyrosine phosphorylation at a YMNM motif within its cytoplasmictail. The phosphorylated motif subsequently interacts with the Src homology2 domain in the p85 regulatory subunit of P13K, activating the p110 catalytic subunit. One of the P13K-dependent downstream targets, resulting from the antibody cross-linking of CD28, is the phoshporylation and activation of Akt (or PKB). Constitutively active Akt is able to substitutefor CD28 signals, and stimulates IL-2 production when introduced into matureCD28-deficient cells. Another molecule affected by CD28 stimulation is theproto-oncogene Vav, which acts as a guanine-nucleotide exchange factor forRac and CDC42, allowing these molecules to switch from the inactive GDP-bound state to the active GTP-bound state [, ].Another interesting feature of CD28, is its ability to induce expression ofPDE7, a cAMP phosphodiesterase, thus reducing cellular cAMP levels. cAMP hasbeen reported to affect nearly every pathway important for lymphocyteactivation, leading to inhibition of T cell proliferation. Specifically,increased intracellular cAMP has been implicated in the induction of T cellanergy, a non-responsive state that occurs after T cells are stimulatedthrough TCR/CD3 in the absence of co-stimulation. This can have therapeutic implications, in that blockage of CD28 co-stimulation can be profoundlyimmunosuppressive, preventing induction of pathogenic T cell responses inautoimmune disease models, and allowing for prolonged acceptance of allografts in models of organ transplantation []. Finally, CD28 co-stimulation directly controls T cell cycle progression by down-regulating the cdk inhibitor p27kip1, which actually integratesmitogenic MEK and P13K-dependent signals from both TCR and CD28 []. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Gross JA |
Year: |
1990 |
Journal: |
J Immunol |
Title: |
The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. |
Volume: |
144 |
Issue: |
8 |
Pages: |
3201-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mittrücker HW |
Year: |
2001 |
Journal: |
J Immunol |
Title: |
Role of CD28 for the generation and expansion of antigen-specific CD8(+) T lymphocytes during infection with Listeria monocytogenes. |
Volume: |
167 |
Issue: |
10 |
Pages: |
5620-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suresh M |
Year: |
2001 |
Journal: |
J Immunol |
Title: |
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. |
Volume: |
167 |
Issue: |
10 |
Pages: |
5565-73 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
218
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
218
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee KP |
Year: |
1990 |
Journal: |
J Immunol |
Title: |
The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. |
Volume: |
145 |
Issue: |
1 |
Pages: |
344-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Appleman LJ |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. |
Volume: |
168 |
Issue: |
6 |
Pages: |
2729-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Frauwirth KA |
Year: |
2002 |
Journal: |
J Clin Invest |
Title: |
Activation and inhibition of lymphocytes by costimulation. |
Volume: |
109 |
Issue: |
3 |
Pages: |
295-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ferguson SE |
Year: |
1996 |
Journal: |
J Immunol |
Title: |
CD28 is required for germinal center formation. |
Volume: |
156 |
Issue: |
12 |
Pages: |
4576-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Boone DL |
Year: |
2002 |
Journal: |
Inflamm Bowel Dis |
Title: |
Interleukin-2-deficient mice develop colitis in the absence of CD28 costimulation. |
Volume: |
8 |
Issue: |
1 |
Pages: |
35-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kondo S |
Year: |
1996 |
Journal: |
J Immunol |
Title: |
Contribution of the CD28 molecule to allergic and irritant-induced skin reactions in CD28 -/- mice. |
Volume: |
157 |
Issue: |
11 |
Pages: |
4822-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mittrücker HW |
Year: |
1999 |
Journal: |
J Immunol |
Title: |
Critical role of CD28 in protective immunity against Salmonella typhimurium. |
Volume: |
163 |
Issue: |
12 |
Pages: |
6769-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Okkenhaug K |
Year: |
2001 |
Journal: |
Nat Immunol |
Title: |
A point mutation in CD28 distinguishes proliferative signals from survival signals. |
Volume: |
2 |
Issue: |
4 |
Pages: |
325-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chapoval SP |
Year: |
2003 |
Journal: |
Clin Immunol |
Title: |
CD28 costimulation is critical for experimental allergic asthma in HLA-DQ8 transgenic mice. |
Volume: |
106 |
Issue: |
2 |
Pages: |
83-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Byrum JN |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
CD28 sensitizes TCR Ca²⁺ signaling during Ag-independent polarization of plasma membrane rafts. |
Volume: |
191 |
Issue: |
6 |
Pages: |
3073-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suzuki T |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Induction of antitumor immune response by homeostatic proliferation and CD28 signaling. |
Volume: |
180 |
Issue: |
7 |
Pages: |
4596-605 |
|
•
•
•
•
•
|
Publication |
First Author: |
Honstettre A |
Year: |
2006 |
Journal: |
Infect Immun |
Title: |
Role for the CD28 molecule in the control of Coxiella burnetii infection. |
Volume: |
74 |
Issue: |
3 |
Pages: |
1800-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yao S |
Year: |
2011 |
Journal: |
Immunity |
Title: |
B7-h2 is a costimulatory ligand for CD28 in human. |
Volume: |
34 |
Issue: |
5 |
Pages: |
729-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Habiro K |
Year: |
2003 |
Journal: |
Transplantation |
Title: |
Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice. |
Volume: |
76 |
Issue: |
5 |
Pages: |
854-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burr JS |
Year: |
2001 |
Journal: |
Am J Respir Cell Mol Biol |
Title: |
CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. |
Volume: |
24 |
Issue: |
5 |
Pages: |
563-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vacchio MS |
Year: |
2003 |
Journal: |
J Exp Med |
Title: |
CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells. |
Volume: |
197 |
Issue: |
1 |
Pages: |
19-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wen T |
Year: |
1997 |
Journal: |
Eur J Immunol |
Title: |
CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors. |
Volume: |
27 |
Issue: |
8 |
Pages: |
1988-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yin D |
Year: |
1999 |
Journal: |
J Immunol |
Title: |
Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. |
Volume: |
163 |
Issue: |
8 |
Pages: |
4328-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vella AT |
Year: |
1997 |
Journal: |
J Immunol |
Title: |
CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. |
Volume: |
158 |
Issue: |
10 |
Pages: |
4714-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saha B |
Year: |
1996 |
Journal: |
J Exp Med |
Title: |
Protection against lethal toxic shock by targeted disruption of the CD28 gene. |
Volume: |
183 |
Issue: |
6 |
Pages: |
2675-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ogawa S |
Year: |
2013 |
Journal: |
Int Immunol |
Title: |
CD28 signaling in primary CD4(+) T cells: identification of both tyrosine phosphorylation-dependent and phosphorylation-independent pathways. |
Volume: |
25 |
Issue: |
12 |
Pages: |
671-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gray Parkin K |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
Expression of CD28 by bone marrow stromal cells and its involvement in B lymphopoiesis. |
Volume: |
169 |
Issue: |
5 |
Pages: |
2292-302 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mathur M |
Year: |
1999 |
Journal: |
Am J Respir Cell Mol Biol |
Title: |
CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice. |
Volume: |
21 |
Issue: |
4 |
Pages: |
498-509 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fukada K |
Year: |
2005 |
Journal: |
Cell Immunol |
Title: |
CD28 is required for induction and maintenance of immunological memory in toxin-reactive CD4+ T cells in vivo. |
Volume: |
238 |
Issue: |
2 |
Pages: |
103-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Compton HL |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. |
Volume: |
168 |
Issue: |
3 |
Pages: |
1302-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gao JX |
Year: |
2004 |
Journal: |
Int Immunol |
Title: |
A new role for CD28 in the survival of autoreactive T cells in the periphery after chronic exposure to autoantigen. |
Volume: |
16 |
Issue: |
10 |
Pages: |
1403-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Elias RM |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
Role of CD28 in polyclonal and specific T and B cell responses required for protection against blood stage malaria. |
Volume: |
174 |
Issue: |
2 |
Pages: |
790-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gause WC |
Year: |
1997 |
Journal: |
J Immunol |
Title: |
CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. |
Volume: |
158 |
Issue: |
9 |
Pages: |
4082-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cong P |
Year: |
2019 |
Journal: |
Oxid Med Cell Longev |
Title: |
CD28 Deficiency Ameliorates Thoracic Blast Exposure-Induced Oxidative Stress and Apoptosis in the Brain through the PI3K/Nrf2/Keap1 Signaling Pathway. |
Volume: |
2019 |
|
Pages: |
8460290 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kimzey SL |
Year: |
2004 |
Journal: |
J Immunol |
Title: |
Requirement for CD28 in the effector phase of allergic airway inflammation. |
Volume: |
173 |
Issue: |
1 |
Pages: |
632-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rivas FV |
Year: |
2001 |
Journal: |
J Immunol |
Title: |
CD28 is not required for c-Jun N-terminal kinase activation in T cells. |
Volume: |
167 |
Issue: |
6 |
Pages: |
3123-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iliopoulou BP |
Year: |
2007 |
Journal: |
J Immunol |
Title: |
CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis. |
Volume: |
179 |
Issue: |
12 |
Pages: |
8076-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sanchez-Lockhart M |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
Cutting edge: A role for inside-out signaling in TCR regulation of CD28 ligand binding. |
Volume: |
187 |
Issue: |
11 |
Pages: |
5515-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu Y |
Year: |
2019 |
Journal: |
Oxid Med Cell Longev |
Title: |
CD28 Deficiency Ameliorates Blast Exposure-Induced Lung Inflammation, Oxidative Stress, Apoptosis, and T Cell Accumulation in the Lungs via the PI3K/Akt/FoxO1 Signaling Pathway. |
Volume: |
2019 |
|
Pages: |
4848560 |
|
•
•
•
•
•
|
Publication |
First Author: |
Leung BL |
Year: |
1999 |
Journal: |
J Immunol |
Title: |
TCR alpha beta-independent CD28 signaling and costimulation require non-CD4-associated Lck. |
Volume: |
163 |
Issue: |
3 |
Pages: |
1334-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Graham DB |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling. |
Volume: |
177 |
Issue: |
9 |
Pages: |
6098-107 |
|
•
•
•
•
•
|
Publication |
First Author: |
Toto P |
Year: |
2000 |
Journal: |
J Immunol |
Title: |
Immune modulation in pemphigus vulgaris: role of CD28 and IL-10. |
Volume: |
164 |
Issue: |
1 |
Pages: |
522-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dodson LF |
Year: |
2009 |
Journal: |
Mol Cell Biol |
Title: |
Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation. |
Volume: |
29 |
Issue: |
13 |
Pages: |
3710-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Harper K |
Year: |
1991 |
Journal: |
J Immunol |
Title: |
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. |
Volume: |
147 |
Issue: |
3 |
Pages: |
1037-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Singh N |
Year: |
2007 |
Journal: |
Blood |
Title: |
Role of CD28 in fatal autoimmune disorder in scurfy mice. |
Volume: |
110 |
Issue: |
4 |
Pages: |
1199-206 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rummel T |
Year: |
2004 |
Journal: |
Infect Immun |
Title: |
CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites. |
Volume: |
72 |
Issue: |
10 |
Pages: |
5768-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fröhlich M |
Year: |
2016 |
Journal: |
Eur J Immunol |
Title: |
Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice. |
Volume: |
46 |
Issue: |
7 |
Pages: |
1644-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Christensen JE |
Year: |
2002 |
Journal: |
Int Immunol |
Title: |
Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells. |
Volume: |
14 |
Issue: |
7 |
Pages: |
701-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Friend LD |
Year: |
2006 |
Journal: |
J Exp Med |
Title: |
A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant. |
Volume: |
203 |
Issue: |
9 |
Pages: |
2121-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. |
Volume: |
169 |
Issue: |
5 |
Pages: |
2236-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Reiter R |
Year: |
2002 |
Journal: |
Immunology |
Title: |
Impaired germinal centre formation and humoral immune response in the absence of CD28 and interleukin-4. |
Volume: |
106 |
Issue: |
2 |
Pages: |
222-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Uri A |
Year: |
2018 |
Journal: |
Eur J Immunol |
Title: |
During acute graft versus host disease CD28 deletion in donor CD8+ , but not CD4+ , T cells maintain antileukemia responses in mice. |
Volume: |
48 |
Issue: |
12 |
Pages: |
2055-2067 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dobbins J |
Year: |
2016 |
Journal: |
Sci Signal |
Title: |
Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling. |
Volume: |
9 |
Issue: |
438 |
Pages: |
ra75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mitra A |
Year: |
2020 |
Journal: |
Front Immunol |
Title: |
CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells. |
Volume: |
11 |
|
Pages: |
735 |
|
•
•
•
•
•
|
Publication |
First Author: |
Leddon SA |
Year: |
2020 |
Journal: |
Front Immunol |
Title: |
The CD28 Transmembrane Domain Contains an Essential Dimerization Motif. |
Volume: |
11 |
|
Pages: |
1519 |
|
•
•
•
•
•
|
Publication |
First Author: |
Noel PJ |
Year: |
1996 |
Journal: |
J Immunol |
Title: |
CD28 costimulation prevents cell death during primary T cell activation. |
Volume: |
157 |
Issue: |
2 |
Pages: |
636-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Andres PG |
Year: |
2004 |
Journal: |
J Immunol |
Title: |
CD28 signals in the immature immunological synapse. |
Volume: |
172 |
Issue: |
10 |
Pages: |
5880-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ndlovu H |
Year: |
2014 |
Journal: |
PLoS Pathog |
Title: |
Inducible deletion of CD28 prior to secondary nippostrongylus brasiliensis infection impairs worm expulsion and recall of protective memory CD4⁺ T cell responses. |
Volume: |
10 |
Issue: |
2 |
Pages: |
e1003906 |
|
•
•
•
•
•
|
Publication |
First Author: |
Villegas EN |
Year: |
1999 |
Journal: |
J Immunol |
Title: |
Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii. |
Volume: |
163 |
Issue: |
6 |
Pages: |
3344-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Oliveira-dos-Santos AJ |
Year: |
1999 |
Journal: |
J Immunol |
Title: |
CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis. |
Volume: |
162 |
Issue: |
8 |
Pages: |
4490-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Béziat V |
Year: |
2021 |
Journal: |
Cell |
Title: |
Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy. |
Volume: |
184 |
Issue: |
14 |
Pages: |
3812-3828.e30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Howland KC |
Year: |
2000 |
Journal: |
J Immunol |
Title: |
The roles of CD28 and CD40 ligand in T cell activation and tolerance. |
Volume: |
164 |
Issue: |
9 |
Pages: |
4465-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alcázar I |
Year: |
2009 |
Journal: |
Blood |
Title: |
p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function. |
Volume: |
113 |
Issue: |
14 |
Pages: |
3198-208 |
|
•
•
•
•
•
|
Publication |
First Author: |
Utley A |
Year: |
2020 |
Journal: |
Cell Rep |
Title: |
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival. |
Volume: |
31 |
Issue: |
12 |
Pages: |
107815 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lyddane C |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Cutting Edge: CD28 controls dominant regulatory T cell activity during active immunization. |
Volume: |
176 |
Issue: |
6 |
Pages: |
3306-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hendriks J |
Year: |
2003 |
Journal: |
J Exp Med |
Title: |
CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. |
Volume: |
198 |
Issue: |
9 |
Pages: |
1369-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gross JA |
Year: |
1992 |
Journal: |
J Immunol |
Title: |
Identification and distribution of the costimulatory receptor CD28 in the mouse. |
Volume: |
149 |
Issue: |
2 |
Pages: |
380-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Felonato M |
Year: |
2010 |
Journal: |
Infect Immun |
Title: |
CD28 exerts protective and detrimental effects in a pulmonary model of paracoccidioidomycosis. |
Volume: |
78 |
Issue: |
11 |
Pages: |
4922-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Andres PG |
Year: |
2004 |
Journal: |
Nat Immunol |
Title: |
Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. |
Volume: |
5 |
Issue: |
4 |
Pages: |
435-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
van den Brandt J |
Year: |
2004 |
Journal: |
Mol Endocrinol |
Title: |
Resistance of single-positive thymocytes to glucocorticoid-induced apoptosis is mediated by CD28 signaling. |
Volume: |
18 |
Issue: |
3 |
Pages: |
687-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Franckaert D |
Year: |
2015 |
Journal: |
Immunol Cell Biol |
Title: |
Promiscuous Foxp3-cre activity reveals a differential requirement for CD28 in Foxp3⁺ and Foxp3⁻ T cells. |
Volume: |
93 |
Issue: |
4 |
Pages: |
417-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vinay DS |
Year: |
2003 |
Journal: |
Immunol Cell Biol |
Title: |
Immunity in the absence of CD28 and CD137 (4-1BB) molecules. |
Volume: |
81 |
Issue: |
3 |
Pages: |
176-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lio CW |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. |
Volume: |
184 |
Issue: |
11 |
Pages: |
6007-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nguyen P |
Year: |
2003 |
Journal: |
Blood |
Title: |
Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function. |
Volume: |
102 |
Issue: |
13 |
Pages: |
4320-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Beyersdorf N |
Year: |
2008 |
Journal: |
Blood |
Title: |
Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody. |
Volume: |
112 |
Issue: |
10 |
Pages: |
4328-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tada Y |
Year: |
1999 |
Journal: |
J Immunol |
Title: |
Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. |
Volume: |
163 |
Issue: |
6 |
Pages: |
3153-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martins GA |
Year: |
2004 |
Journal: |
Microbes Infect |
Title: |
CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection. |
Volume: |
6 |
Issue: |
13 |
Pages: |
1133-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ekkens MJ |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
Memory Th2 effector cells can develop in the absence of B7-1/B7-2, CD28 interactions, and effector Th cells after priming with an intestinal nematode parasite. |
Volume: |
168 |
Issue: |
12 |
Pages: |
6344-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Abe R |
Year: |
1995 |
Journal: |
J Immunol |
Title: |
Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation. |
Volume: |
154 |
Issue: |
3 |
Pages: |
985-97 |
|
•
•
•
•
•
|
Publication |
First Author: |
Boomer JS |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression. |
Volume: |
192 |
Issue: |
8 |
Pages: |
3465-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yousefi M |
Year: |
2013 |
Journal: |
Eur J Immunol |
Title: |
CD28 controls the development of innate-like CD8+ T cells by promoting the functional maturation of NKT cells. |
Volume: |
43 |
Issue: |
11 |
Pages: |
3017-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sempowski GD |
Year: |
2004 |
Journal: |
J Immunol |
Title: |
CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis. |
Volume: |
172 |
Issue: |
2 |
Pages: |
787-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shilling RA |
Year: |
2009 |
Journal: |
Cell Immunol |
Title: |
CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. |
Volume: |
259 |
Issue: |
2 |
Pages: |
177-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Toyo-oka K |
Year: |
1997 |
Journal: |
Immunol Lett |
Title: |
Synergy between CD28 and CD9 costimulation for naive T-cell activation. |
Volume: |
58 |
Issue: |
1 |
Pages: |
19-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Win SJ |
Year: |
2016 |
Journal: |
Eur J Immunol |
Title: |
In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice. |
Volume: |
46 |
Issue: |
5 |
Pages: |
1193-202 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fang M |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host. |
Volume: |
177 |
Issue: |
11 |
Pages: |
8027-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Demirci G |
Year: |
2004 |
Journal: |
J Immunol |
Title: |
Critical role of OX40 in CD28 and CD154-independent rejection. |
Volume: |
172 |
Issue: |
3 |
Pages: |
1691-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang Q |
Year: |
2003 |
Journal: |
J Immunol |
Title: |
Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. |
Volume: |
171 |
Issue: |
7 |
Pages: |
3348-52 |
|
•
•
•
•
•
|